Intelligence · Clinical Development
Pipeline search results
Programs matching “omid” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 143 pipeline programs matching "omid" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dexmedetomidine
BioXcel Therapeutics
Schizophrenia Agitation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dexmedetomidine Injectable Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
Esketamine combined with dexmedetomidine
The First People's Hospital of Lianyungang
Dexmedetomidine
2 trials -
Etomidate
Hospital Authority, Hong Kong
Choledocholithiasis
1 trial -
Intranasal dexmedetomidine-esketamine
The First People's Hospital of Lianyungang
Adenotonsillectomy
1 trial -
K9520
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
Rocuronium Bromide
ELITE PHARMACEUTICALS INC /NV/
Muscle Relaxation
1 trial -
Temozolomide
Monte Rosa Therapeutics
Brain Neoplasms, Malignant, Primary
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
dexmedetomidine
Pfizer
MRI Sedation
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Aged
3 trials -
dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sleep Quality of Patients Undergoing TURP
1 trial -
dexmedetomidine hydrochloride for injection
The First People's Hospital of Lianyungang
Delirium
1 trial -
20250527IIT0060
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dexmedetomidine Induced Sedation
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchoscopy
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Dexmedetomidine
1 trial -
Dexmedetomidine
Shiyou Wei
Lung Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.